# Glycopyrrolate

NDC: 71288-414
Generic name: Glycopyrrolate
Labeler / Manufacturer: Meitheal Pharmaceuticals Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION
Routes: INTRAMUSCULAR, INTRAVENOUS
Marketing started: 20210706

FDA application: ANDA212802

## Active ingredients

- GLYCOPYRROLATE: .2 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"71288-414"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=71288-414
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=02541cfd-b209-49b9-a73f-13ef18dce06d